When will Compass Pathways submit a NDA for COMP360 psilocybin?
14.0 Pkt. (24h)Health & MedicineOne-OffWissenschaftBusiness & Corporate21T
KalshiVerfügbarkeit prüfenKYC erforderlich2% GebührVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle implizite Wahrscheinlichkeit
before April 2027 83%Führend unter 6 Optionen
Marktqualitat
42 / 100
Niedrige Qualität24h-Volumen
997,3 €
Liquidität
8661,8 €
Mittlere LiquiditätSpread
20.0 pt
Breiter SpreadMarktdaten
Aktualisiert vor 8 Minuten
24. März 26, 14:00 UTC1. Okt. 26, 14:00 UTC
Trends
Verwandte Märkte
Verwandte Fragen als Kontext, kein Vergleich gleichwertiger Kontrakte.
When will the FDA approve Compass Pathways' COMP360 Psilocybin?
Kalshi[ACX 2026] Will the FDA approve a psilocybin treatment during 2026?
Manifold MarketsWill psilocybin remain Schedule I through the end of 2027?
Manifold MarketsWill the FDA approve a psilocybin treatment during 2026?
FutuurWhich fast food chain in the USA will offer a lab-grown / cultivated meat product first?
Manifold MarketsWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiRegeln
If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Sep 1, 2026, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Oct 1, 2026, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Nov 1, 2026, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Dec 1, 2026, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Jan 1, 2027, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.
Offene Märkte
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No-0.2pt97%
- Yes+0.2pt3%
- Gesamtvolumen
- 15,6 Mio. €
- 24h-Volumen
- 30.387,4 €
POLYMARKETEbola pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Gesamtvolumen
- 652.807,7 €
- 24h-Volumen
- 3547,3 €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No97%
- Yes-0.7pt3%
- Gesamtvolumen
- 1,6 Mio. €
- 24h-Volumen
- 2906,5 €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 4000+1.0pt97%
- Above 600059%
+2 weitere Ergebnisse
- Gesamtvolumen
- 865.320,4 €
- 24h-Volumen
- 2719,4 €
POLYMARKETNew pandemic in 2026?
- No+1.0pt94.1%
- Yes-1.0pt5.9%
- Gesamtvolumen
- 915.253 €
- 24h-Volumen
- 1382,5 €
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+1.0pt65%
- September41%
- June28%
- Gesamtvolumen
- 84.047,3 €
- When will the FDA approve Intellia Therapeutics' lonvo-z?
- Will 3 mg THC beverages be federally legal to sell?
- Cyclosporiasis cases reported in the US in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve CagriSema?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Measles cases in U.S. in 2026?
- FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (in 2026)
- FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (in 2026)
- Heidi Overton confirmed as FDA Commissioner by which date?
Häufige Fragen
- Wie stehen die aktuellen Quoten für When will Compass Pathways submit a NDA for COMP360 psilocybin??
- Kalshi bewertet before April 2027 mit 83% (Stand: 9. September 2026).
- Wann wird When will Compass Pathways submit a NDA for COMP360 psilocybin? entschieden?
- When will Compass Pathways submit a NDA for COMP360 psilocybin? soll am 1. Oktober 2026 entschieden werden.
- Wie wird When will Compass Pathways submit a NDA for COMP360 psilocybin? abgerechnet?
- Kalshi rechnet diesen Markt wie folgt ab: If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Sep 1, 2026, then the market resolves to Yes.